Literature summary for 3.4.23.47 extracted from

Ruelle, J.; Roman, F.; Vandenbroucke, A.T.; Lambert, C.; Fransen, K.; Echahidi, F.; Pierard, D.; Verhofstede, C.; Van Laethem, K.; Delforge, M.L.; Vaira, D.; Schmit, J.C.; Goubau, P.
Transmitted drug resistance, selection of resistance mutations and moderate antiretroviral efficacy in HIV-2: analysis of the HIV-2 Belgium and Luxembourg database (2008), BMC Infect. Dis., 8, 21.

Search for more literature for 3.4.23.47

Protein Variants

Protein Variants	Comment	Organism
V71I, L90M, I89V	most frequently detected mutations within PR selected under antiretroviral drug therapy in a clinical cohort study with 25 patients treated with antiretroviral therapy	Human immunodeficiency virus 2

Organism

Organism	UniProt	Comment	Textmining
Human immunodeficiency virus 2	-	isolate EHO subtype B	-

Synonyms

Synonyms	Comment	Organism
PR	-	Human immunodeficiency virus 2

Use of this online version of BRENDA is free under the CC BY 4.0 license. See terms of use for full details.

Release 2023.1 (January 2023)